Elisabeth Kogan
Director/Board Member chez MEDINCELL S.A.
Fortune : 77 679 $ au 31/03/2024
Profil
Elisabeth Kogan is the founder of Clexio Biosciences Ltd.
She currently holds a position as a Member-Supervisory Board at MedinCell SA.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MEDINCELL SA
0,03% | 31/03/2023 | 7 500 ( 0,03% ) | 77 679 $ | 31/03/2024 |
Postes actifs de Elisabeth Kogan
| Sociétés | Poste | Début |
|---|---|---|
| MEDINCELL S.A. | Director/Board Member | 15/12/2020 |
Clexio Biosciences Ltd.
 Clexio Biosciences Ltd. Pharmaceuticals: OtherHealth Technology Clexio Biosciences Ltd. develops novel therapies for patients suffering from neurological and psychiatric conditions. The private company is based in Jerusalem, Israel. The Israeli company was founded by Elena Kagan, Elisabeth Kogan, Menashe Levy. Elisabeth Kogan has been the CEO since incorporation. | Founder | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDINCELL S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Clexio Biosciences Ltd.
Clexio Biosciences Ltd. Pharmaceuticals: OtherHealth Technology Clexio Biosciences Ltd. develops novel therapies for patients suffering from neurological and psychiatric conditions. The private company is based in Jerusalem, Israel. The Israeli company was founded by Elena Kagan, Elisabeth Kogan, Menashe Levy. Elisabeth Kogan has been the CEO since incorporation. | Health Technology |
